There are very little data on the polymorphisms and haplotypes of ERCC2 in different populations. A closer examination of ERCC2 is necessary, especially in the promoter region, in order to determine ...
Somatic mutations in the helicase-encoding ERCC2 gene are associated with response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive urothelial bladder carcinoma. Among 48 ...
Interim results from a multicenter clinical study of tislelizumab combined with gemcitabine and cisplatin as neoadjuvant therapy for patients with cT2-T4aN0M0 MIBC. This is an ASCO Meeting Abstract ...
Preoperative serum CA125 as an independent predictor for recurrence and death in operable patients with non-small cell lung cancer. This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I ...
To evaluate the relationship of genetic polymorphisms of ERCC2 and ERCC4 genes, both involved in nucleotide excision repair (NER), and the risk of breast cancer, a hospital-based case-control study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results